Phase III trial with Catena® for the treatment of Duchenne Muscular Dystrophy
April 27, 2009 by CureDuchenne
Filed under Research Articles
To Read the article in full,
*
*
Related posts:
- Acceleron Pharma Initiates Phase 2 Clinical Trial with ACE-031 in Patients with Duchenne Muscular Dystrophy Be sure to take some time to read this important...
- Acceleron Pharma`s ACE-031 Increases Lean Body Mass in Phase 1 Single Dose Clinical Trial Please take some time to read this important report: Acceleron...
- PTC Therapeutics and Genzyme Corporation Announce Preliminary Results from the Phase 2b Clinical Trial Please take some time to read this important announcement: PTC...
- Acceleron initiates trial for Duchenne muscular dystrophy for ACE-031 Acceleron has announced their trial for DMD. Read here to...
- BioMarin Initiates Phase 1 Clinical Study of BMN 195 for Duchenne Muscular Dystrophy Please take some time to read this important press release...
Related posts brought to you by Yet Another Related Posts Plugin.
